97 related articles for article (PubMed ID: 21554254)
1. EMMPRIN levels in serum of patients with amyotrophic lateral sclerosis.
Iłżecka J
Acta Neurol Scand; 2011 Dec; 124(6):424-8. PubMed ID: 21554254
[TBL] [Abstract][Full Text] [Related]
2. Granzymes A and B levels in serum of patients with amyotrophic lateral sclerosis.
Iłżecka J
Clin Biochem; 2011 Jun; 44(8-9):650-3. PubMed ID: 21349256
[TBL] [Abstract][Full Text] [Related]
3. Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2009 Aug; 120(2):119-22. PubMed ID: 19053950
[TBL] [Abstract][Full Text] [Related]
4. Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2008 May; 117(5):343-6. PubMed ID: 17995989
[TBL] [Abstract][Full Text] [Related]
5. Serum soluble OX40 in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Clin Croat; 2012 Mar; 51(1):3-7. PubMed ID: 22919996
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of matrix metalloproteinases in serum of patients with amyotrophic lateral sclerosis with pattern recognition methods.
Sokolowska B; Jozwik A; Niebroj-Dobosz I; Janik P; Kwiecinski H
J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():117-20. PubMed ID: 20134051
[TBL] [Abstract][Full Text] [Related]
8. Increased serum CNTF level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Eur Cytokine Netw; 2003; 14(3):192-4. PubMed ID: 14656696
[TBL] [Abstract][Full Text] [Related]
9. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
[TBL] [Abstract][Full Text] [Related]
10. Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid.
Kaushik DK; Yong HY; Hahn JN; Silva C; Casha S; Hurlbert RJ; Jacques FH; Lisak R; Khan O; Ionete C; Larochelle C; Prat A; Bar-Or A; Yong VW
PLoS One; 2016; 11(10):e0163802. PubMed ID: 27727297
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z; Dobosz B
Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
[TBL] [Abstract][Full Text] [Related]
12. The role of soluble intercellular adhesion molecules in neurodegenerative disorders.
Rentzos M; Michalopoulou M; Nikolaou C; Cambouri C; Rombos A; Dimitrakopoulos A; Vassilopoulos D
J Neurol Sci; 2005 Feb; 228(2):129-35. PubMed ID: 15694193
[TBL] [Abstract][Full Text] [Related]
13. Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS).
Fang L; Huber-Abel F; Teuchert M; Hendrich C; Dorst J; Schattauer D; Zettlmeissel H; Wlaschek M; Scharffetter-Kochanek K; Tumani H; Ludolph AC; Brettschneider J
J Neurol Sci; 2009 Oct; 285(1-2):62-6. PubMed ID: 19523650
[TBL] [Abstract][Full Text] [Related]
14. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
15. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.
Zoccolella S; Simone IL; Lamberti P; Samarelli V; Tortelli R; Serlenga L; Logroscino G
Neurology; 2008 Jan; 70(3):222-5. PubMed ID: 18195267
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Rentzos M; Rombos A; Nikolaou C; Zoga M; Zouvelou V; Dimitrakopoulos A; Alexakis T; Tsoutsou A; Samakovli A; Michalopoulou M; Evdokimidis I
Eur Neurol; 2010; 63(5):285-90. PubMed ID: 20407265
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of CD147 in genitourinary carcinomas.
Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
[TBL] [Abstract][Full Text] [Related]
18. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
[TBL] [Abstract][Full Text] [Related]
19. Extracellular matrix metalloproteinase inducer (EMMPRIN) is increased in human left ventricle after acute myocardial infarction.
Nie R; Xie S; Du B; Liu X; Deng B; Wang J
Arch Med Res; 2009 Oct; 40(7):605-11. PubMed ID: 20082877
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of soluble intercellular adhesion molecule-1 (s-ICAM-1) and soluble endothelial leukocyte adhesion molecule-1(s-ELAM-1) in amyotrophic lateral sclerosis.
Rentzos M; Michalopoulou M; Nikolaou C; Rombos A; Dimitrakopoulos A
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Jun; 6(2):118-21. PubMed ID: 16036437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]